PD-L1 (E1L3N) Antibody Kit (IHC)

PD-L1 (E1L3N) Antibody Kit (IHC)

Cancer Related Care

Information

PD-L1 (E1L3N) antibody kit (IHC) are used for in vitro qualitative testing of the protein expression of Programmed Death-Ligand 1 (PD-L1) in 4% neutral (phosphate buffered) formalin-fixed, paraffin-embedded (FFPE) NSCLC to assist with identifying lung cancer patients who can be treated with PD-1 inhibitor drug OPDIVO®(Bristol-Myers Squibb,Nivolumab). The PD-L1 IHC Kit (CE IVD) is a standardized IHC assay with all necessary components for 15, 30 or 50 tests in one kit.
MEDx Translational Medicine Co.,LtdH7.C52MEDx Translational Medicine Co., Ltd (simply MEDx) was founded in 2013, formerly known as the Translational Medicine Research Center of QIAGEN China. As a leader of Companion Diagnostics Total-Solution Providers, MEDx provides comprehensive translational medicine support in the development of new drugs and companion diagnostics (CDx) in oncology, and offers clinical testing for Precision Medicine.

Log in